These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4969441)

  • 21. [Immunochemical characteristics of 2 geographic strains of tularemia microbes].
    Rodionova IV; Shipitsina GK
    Biokhimiia; 1967; 32(6):1161-8. PubMed ID: 4969633
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunochemistry of K antigens of Escherichia coli. 5. The K antigen of E. coli 08:K27(A):H negative.
    Jann K; Jann B; Schneider KF; Orskov F; Orskov I
    Eur J Biochem; 1968 Sep; 5(4):456-65. PubMed ID: 4972384
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunological analysis of spores of Clostridium botulinum type E.
    Law SW; Hawirko RZ
    Can J Microbiol; 1969 Dec; 15(12):1427-31. PubMed ID: 4983961
    [No Abstract]   [Full Text] [Related]  

  • 24. [Preparative separation of toxin and prototoxin from CL. botulinum type B cells].
    Ivanova LG; Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):115-8. PubMed ID: 4218008
    [No Abstract]   [Full Text] [Related]  

  • 25. The antigenic structure of Francisella tularensis. I. Isolation of the ether antigen and its fractionation.
    Procházka O; Dubanská H
    Folia Microbiol (Praha); 1972; 17(3):232-8. PubMed ID: 4624012
    [No Abstract]   [Full Text] [Related]  

  • 26. [Insoluble antigens in the identification of Cl. botulinum. II. Agglutination and hemagglutination studies and complement fixation reaction].
    Cygan Z
    Pol Arch Weter; 1973; 16(1):47-64. PubMed ID: 4132768
    [No Abstract]   [Full Text] [Related]  

  • 27. Blocking of antibody passive hemagglutination reaction (Bl-AbHAp) as a test for in vitro recognition of type-specific soluble antigens of Clostridium botulinum.
    Ligieza J; Reiss J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):183-7. PubMed ID: 3539066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b.
    Schneerson R; Bradshaw M; Whisnant JK; Myerowitz RL; Parke JC; Robbins JB
    J Immunol; 1972 Jun; 108(6):1551-62. PubMed ID: 4624175
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The immunochemical and biological properties of botulin type A toxoids. I].
    Golshmid VK; Drachennikov VI; Rezepov FF; Chentsova OI
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Aug; 47(8):44-9. PubMed ID: 4925423
    [No Abstract]   [Full Text] [Related]  

  • 31. A 'new' saliva substance, probably inherited, and serologically independent of ABH, Lewis, and Sda blood group substances.
    Balding P; Gold ER
    J Med Genet; 1973 Dec; 10(4):323-7. PubMed ID: 4204386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and characterization of serologically active cell wall substances from Planococcus strains.
    Endresen C; Oeding P
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Oct; 81(5):571-5. PubMed ID: 4134798
    [No Abstract]   [Full Text] [Related]  

  • 33. [A study of botulin toxins and anatoxins by the gel filtration method. I. Studies of botulin toxins and anatoxins types A and C by filtration through Sephadex G-100].
    Freĭman VB; Golshmid VK
    Zh Mikrobiol Epidemiol Immunobiol; 1966 May; 43(5):52-8. PubMed ID: 4975811
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies of soluble antigens of Clostridium bifermentans by gel precipitation method].
    Komorowski A; Zahaczewski J
    Med Dosw Mikrobiol; 1969; 21(1):45-8. PubMed ID: 4978100
    [No Abstract]   [Full Text] [Related]  

  • 35. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.
    Sakaguchi G; Sakaguchi S; Kozaki S; Sugii S; Oishi I
    Jpn J Med Sci Biol; 1974 Jun; 27(3):161-72. PubMed ID: 4604281
    [No Abstract]   [Full Text] [Related]  

  • 36. Observations on receptor specific proteins. II. Haemagglutination and haemagglutination-inhibition reactions of Clostridium botulinum types A, C, D and E haemagglutinins.
    Balding P; Gold ER; Boroff DA; Roberts TA
    Immunology; 1973 Nov; 25(5):773-82. PubMed ID: 4586739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure and immunological properties of D-arabino-D-galactans isolated from cell walls of Mycobacterium species.
    Misaki A; Seto N; Azuma I
    J Biochem; 1974 Jul; 76(1):15-27. PubMed ID: 4215801
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of laboratory tests for the detection of enterotoxigenic Clostridium perfringens.
    Niilo L
    Can J Microbiol; 1978 May; 24(5):633-5. PubMed ID: 207403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group).
    Dhir SP; Hakomori S; Kenny GE; Grayston JT
    J Immunol; 1972 Jul; 109(1):116-22. PubMed ID: 4338437
    [No Abstract]   [Full Text] [Related]  

  • 40. Antigenicity of Clostridium botulinum type-E formol toxoid.
    Kondo H; Kondo S; Murata R; Sakaguchi G
    Jpn J Med Sci Biol; 1969 Apr; 22(2):75-85. PubMed ID: 4899485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.